Navin Fluorine International Announces Key Leadership Changes in CDMO Business

2 min read     Updated on 25 Aug 2025, 06:10 PM
scanx
Reviewed by
Ashish ThakurBy ScanX News Team
whatsapptwittershare
Overview

Navin Fluorine International Limited has announced key leadership changes in its CDMO Business division. Mr. Rajendra Sahu, the current CEO, will step down on September 20, 2025. Dr. Vijay Kaiwar has been appointed as the new CEO Designate, taking full responsibilities from September 21, 2025. Dr. Kaiwar brings nearly 30 years of experience in CDMO and API businesses, with expertise in various functions and technologies. He holds a Ph.D. in Organic Chemistry and has held senior roles at several renowned pharmaceutical companies.

17671235

*this image is generated using AI for illustrative purposes only.

Navin Fluorine International Limited , a prominent player in the fluorochemicals industry, has announced significant leadership changes in its Contract Development and Manufacturing Organization (CDMO) Business division, signaling a new chapter for the company's strategic growth.

Departure of Current CEO

Mr. Rajendra Sahu, the current CEO of the CDMO Business, has tendered his resignation to pursue career opportunities elsewhere. His tenure with Navin Fluorine International will conclude on September 20, 2025, marking the end of his leadership in this crucial division.

Appointment of New CEO

In a strategic move to ensure a smooth transition and continued growth, Navin Fluorine International has appointed Dr. Vijay Kaiwar as the CEO Designate of the CDMO Business. Dr. Kaiwar will assume full CEO responsibilities effective September 21, 2025, bringing with him a wealth of experience and expertise to the role.

Dr. Vijay Kaiwar's Profile

Dr. Kaiwar joins Navin Fluorine International with an impressive background:

  • Nearly 30 years of experience in CDMO and API businesses
  • Specialization in Chemistry and Biotechnology
  • Leadership exposure across multiple functions, including R&D, Technology Transfer, Operations, Projects, Manufacturing, EHS, and Business Development
  • Senior leadership roles at renowned companies such as Anthem Biosciences, Sun Pharma, Aurobindo Pharma, Jubilant Organosys, and Atul Limited
  • Strong partnerships with leading global pharmaceutical and biotech companies
  • Expertise in regulatory affairs and a broad spectrum of technologies

Educational Background

Dr. Kaiwar's academic credentials further underscore his expertise in the field:

  • Ph.D. in Organic Chemistry from IICT Hyderabad
  • Post-Doctoral Fellowship from King's College, London

Impact on Navin Fluorine International

The appointment of Dr. Kaiwar is expected to bring fresh perspectives and deep industry knowledge to Navin Fluorine International's CDMO Business. His extensive experience in building partnerships with global pharmaceutical clients and expertise in various advanced technologies aligns well with the company's focus on innovation and growth in the CDMO sector.

This leadership transition comes at a time when the CDMO industry is experiencing significant growth and transformation. Dr. Kaiwar's diverse skill set and experience in managing high-performing teams are likely to be valuable assets as Navin Fluorine International seeks to strengthen its position in the global CDMO market.

The company's proactive approach in announcing these changes well in advance demonstrates its commitment to ensuring a smooth transition and maintaining stakeholder confidence. As Navin Fluorine International embarks on this new phase under Dr. Kaiwar's leadership, the industry will be watching closely to see how these changes shape the company's future trajectory in the competitive CDMO landscape.

Historical Stock Returns for Navin Fluorine International

1 Day5 Days1 Month6 Months1 Year5 Years
-4.06%-4.66%-6.01%+27.09%+45.09%+124.62%
Navin Fluorine International
View in Depthredirect
like18
dislike

Navin Fluorine International Expands Green Power Portfolio with Strategic Investment

2 min read     Updated on 05 Aug 2025, 08:14 PM
scanx
Reviewed by
Jubin VergheseBy ScanX News Team
whatsapptwittershare
Overview

Navin Fluorine International Limited (NFIL) is acquiring a 26% stake in Pro-Zeal Green Power Eleven Private Limited for ₹6.60 crores, securing 6.60 MW of captive hybrid wind and solar power for its Surat unit. The company reported impressive financial results with revenue up 39% to ₹725.00 crores, operating EBITDA up 106% to ₹207.00 crores, and net profit up 129% to ₹117.00 crores. NFIL's business segments show positive developments, including successful commercialization of the R32 project, progress in specialty chemicals, and strong momentum in the CDMO division.

15950705

*this image is generated using AI for illustrative purposes only.

Navin Fluorine International Limited (NFIL) has made a significant move towards sustainability and cost efficiency by entering into agreements to acquire a 26% stake in Pro-Zeal Green Power Eleven Private Limited (SPV) for up to ₹6.60 crores. This strategic investment aligns with the company's commitment to renewable energy and operational cost optimization.

Key Highlights of the Investment

  • Stake Acquisition: NFIL will invest up to ₹6.60 crores through equity shares and compulsory convertible debentures in the SPV.
  • Power Supply Agreement: The SPV will provide 6.60 MW of captive hybrid wind and solar power to NFIL's Surat unit under a 15-year agreement.
  • Ownership Structure: NFIL will hold a 26% stake, while the remaining 74% will be held by Prozeal Green Power Private Limited.
  • Expected Completion: The acquisition is set to be completed within 11 months.

Strategic Implications

The investment in Pro-Zeal Green Power Eleven Private Limited is expected to yield significant benefits for Navin Fluorine:

  1. Cost Savings: The arrangement aims to achieve substantial savings on power costs for the Surat unit.
  2. Sustainability Goals: This move aligns with NFIL's sustainability objectives, showcasing its commitment to renewable energy sources.
  3. Long-term Energy Security: The 15-year power supply agreement ensures a stable and predictable energy supply for the Surat facility.

Financial Performance

Navin Fluorine International Limited has reported strong financial results:

Metric Value Year-on-Year Change
Revenue ₹725.00 crores Up 39%
Operating EBITDA ₹207.00 crores Up 106%
Net Profit ₹117.00 crores Up 129%
Operating EBITDA Margin 28.50% Improved by 935 basis points

Business Segment Updates

High-Performance Products (HPP)

  • R32 project successfully commercialized and running at optimal capacity
  • AHF project progressing steadily

Specialty Chemicals

  • Set to deliver supplies for 3 new molecules
  • Fluoro specialty project in Dahej expected to contribute meaningfully

Contract Development and Manufacturing Organization (CDMO)

  • Strong order book momentum continues
  • cGMP4 facility Phase 1 expansion on track

Future Outlook

Navin Fluorine International Limited is well-positioned for growth across its business segments. The company's strategic investments in green energy, expansion of specialty chemicals portfolio, and progress in the CDMO division indicate a positive outlook.

The management remains focused on enhancing value addition, targeting high-margin opportunities, and diversifying into emerging high-growth sectors. With a strong balance sheet following the recent ₹750.00 crores QIP, NFIL is poised to capitalize on new opportunities and drive sustainable growth.

As Navin Fluorine continues to expand its capabilities in advanced materials and electronic chemicals, the company is set to strengthen its position in niche, high-value markets while maintaining its commitment to sustainability and operational excellence.

Historical Stock Returns for Navin Fluorine International

1 Day5 Days1 Month6 Months1 Year5 Years
-4.06%-4.66%-6.01%+27.09%+45.09%+124.62%
Navin Fluorine International
View in Depthredirect
like17
dislike
More News on Navin Fluorine International
Explore Other Articles
4,796.00
-203.00
(-4.06%)